北京出新规,门诊患者可自主选择购药渠道

北京出新规,门诊患者可自主选择购药渠道


Yesterday, the "Beijing's Implementation Plan for Further Reform and Improvement of Drug Production, Circulation and Use Policy" (hereinafter referred to as the "implementation plan") was officially released, and the 23 new policies related to drug approval, supply, procurement and distribution, drug price monitoring, and drug cost control Wait. According to the "Implementation Plan", outpatients can choose to purchase medicines at medical institutions or retail pharmacies. Medical institutions must not restrict outpatients to purchase medicines from retail pharmacies on the basis of prescriptions.

During the year, the city implemented a "two-vote system" for drugs

At the beginning of this year, the State Council's Medical Reform Office and other seven ministries, commissions, and offices jointly issued the "Notice on the Implementation of the" Two-Vote System "in the Procurement of Drugs in Public Medical Institutions (Trial)", requiring public hospital reform pilot cities to take the lead "Two-vote system". In response, the "Implementation Plan" pointed out that in conjunction with the "Notice", the detailed implementation rules of Beijing's "two-vote system" will be formulated and strived to be rolled out throughout the city by the end of 2017.

The Beijing Youth Daily reporter learned that the "two-vote system" means that the pharmaceutical company issues an invoice once from the manufacturer to the circulation company, and the circulation company issues a invoice to the medical institution. The purpose of this move is to compress the circulation of medicines, make the intermediate price increase transparent, and further promote the reduction of inflated medicine prices.

The new measures also emphasized that reasonable control of medical expenses, control of unreasonable increase in medical expenses, and implementation in medical institutions will be implemented. The control of medical expenses will be included in the government's comprehensive performance evaluation of public hospitals, and the control of medical expenses in various districts and medical institutions will be publicized regularly.

Outpatients can choose their own drug purchase channels

The "Implementation Plan" proposes that medical institutions should issue prescriptions according to the generic names of drugs and relevant regulations, and proactively provide prescriptions to patients. Outpatients may choose to purchase medicines from medical institutions or retail pharmacies. Medical institutions may not restrict outpatients to purchase medicines from retail pharmacies on the basis of prescriptions. At the same time, Beijing will explore the interconnection and real-time sharing of prescription information of medical institutions and retail drug consumption information.

Beijing will also promote “Internet + Drug Circulation”, promote new delivery methods such as “online order store pick-up” and “online order store delivery” to reduce transaction costs. In this regard, Beijing will study related policies on third-party platforms for online drug retail transactions and distribution services, strengthen Internet drug information and transaction service supervision, and ensure the safety of drug distribution processes.

For the monitoring measures of drug prices, according to the Implementation Plan, Beijing will implement a traceability mechanism for ex-factory drug price information and explore the establishment of a unified city-wide cross-department price information platform. The information platform will be interconnected with the comprehensive management platform for pharmaceutical sunlight procurement and the medical insurance payment review platform, and will also be shared with relevant tax data.

In addition, the city will also improve the monitoring system for drug prices, and will conduct special cost-price investigations for drugs that have abnormal price changes or that differ greatly from the prices of the same product.

Pharmaceutical companies will be prohibited from purchasing drugs for 2 years if they do not supply them in a timely manner.

Drug distribution is directly related to the use of medical institutions. The "Implementation Plan" clearly states that pharmaceutical companies that supply medicines in a timely manner and cause adverse consequences will be required to withdraw from the sunshine procurement platform, and public hospitals shall not purchase their medicines for 2 years.

Pharmaceutical production and distribution enterprises and medical institutions shall voluntarily sign ordering and sales contracts in accordance with laws and regulations to ensure timely production, distribution and payment settlement of drugs. For companies that violate the contract and the supply or distribution does not affect the clinical use of drugs in a timely manner, they shall bear the corresponding liabilities for breach of contract in accordance with the contract. The website is announced to the public; if the circumstances are serious and cause adverse consequences, the company will withdraw from the sunshine procurement platform, and public medical institutions shall not purchase its medicines within 2 years.

In the context of decentralized clothing, according to the "Implementation Plan", for the urgent need of new drugs in clinical practice, drugs included in the national science and technology major and key R & D plans, and innovative new drugs with obvious therapeutic advantages, these drugs will improve the acceptance and initial review timeliness.




[marked] more medicine professional career development information, small font just below the blue click on the title " Medical grade non-mainstream " / Search public number concern" non-mainstream health staff, exchange of pharmaceutical professionals with your "non "Mainstream" career development information to create the peak of career development. Please share this information to your WeChat circle of friends after reading, thank you!

This platform consists of dedicated life sciences executive search firm DOX jobs responsible for editing, sharing the most comprehensive career development plan for the medical workers to provide the most extensive pharmaceutical industry. More information: www.chinadox.com